Globalex Pharma OÜRegistered
Key figures
16 102 894 €+50,7%
Revenue 2025
+56,4%
Average annual growth 2019–2025
Ratios
20254,0%
Profit margin
3,6%
EBITDA margin
33,7%
Equity ratio
1,2×
Current ratio
35,5%
Return on equity
1434 €
Average gross salary
Profit exceeds EBITDA because of financial income (e.g. dividends or interest), which EBITDA does not include.
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q2 2026 | 4 943 802 € | 5 | 10 762 € |
| Q1 2026 | 5 634 411 € | 5 | 10 624 € |
| Q4 2025 | 3 678 984 € | 5 | 10 288 € |
| Q3 2025 | 10 184 186 € | 5 | 12 201 € |
| Q2 2025 | 4 132 958 € | 4 | 11 422 € |
| Q1 2025 | 5 853 948 € | 5 | 10 908 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 317 133 | 494 378 | 693 790 | 906 617 | 1 112 452 | 1 885 994 | 4 156 165 |
| Total non-current assets | — | — | 61 449 | 26 446 | 19 997 | 417 268 | 1 156 260 |
| Total assets | 317 133 | 494 378 | 755 239 | 933 063 | 1 132 449 | 2 303 262 | 5 312 425 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 88 503 | 177 166 | 438 944 | 423 395 | 388 950 | 1 130 991 | 3 519 730 |
| Non-current liabilities | — | — | 86 289 | 26 857 | 22 293 | 16 729 | 0 |
| Total liabilities | 88 503 | 177 166 | 525 233 | 450 252 | 411 243 | 1 147 720 | 3 519 730 |
| Share capital | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 | 2556 |
| Retained earnings of previous periods | 160 020 | 225 818 | 314 400 | 227 193 | 479 999 | 718 394 | 1 152 730 |
| Profit for the year | 65 798 | 88 582 | −87 206 | 252 806 | 238 395 | 434 336 | 637 153 |
| Reserves and other equity | 256 | 256 | 256 | 256 | 256 | 256 | 256 |
| Total equity | 228 630 | 317 212 | 230 006 | 482 811 | 721 206 | 1 155 542 | 1 792 695 |
| Income statement | |||||||
| Sales revenue | 1 099 674 | 1 610 898 | 1 832 803 | 7 899 136 | 7 483 651 | 10 682 780 | 16 102 894 |
| Operating profit | 69 596 | 94 081 | −33 086 | 267 754 | 243 218 | 423 309 | 555 717 |
| EBITDA | — | — | −25 697 | 277 562 | 249 667 | 429 949 | 575 126 |
| Profit before income tax | 65 798 | 88 582 | −87 206 | 252 806 | 238 395 | 434 336 | 637 153 |
| Profit for the reporting year | 65 798 | 88 582 | −87 206 | 252 806 | 238 395 | 434 336 | 637 153 |
| Labour costs | 30 149 | 12 587 | 14 793 | 57 322 | 71 615 | 85 416 | 93 909 |
| Depreciation of non-current assets | — | — | 7389 | 9808 | 6449 | 6640 | 19 409 |
| Other indicators | |||||||
| Employees | 1 | 1 | 2 | 2 | 3 | 4 | 4 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Connections graph
Click a node to see its other connections.
CompanyPersonShareholderOther roleAdditional link
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
Same activity — Ravimite ja muude apteegikaupade hulgimüük